Lucintel Forecasts Regenerative Medicine Market to Reach $24.3 Billion by 2027

Category: Business

According to the recent study the regenerative medicine market is projected to reach an estimated $24.3 billion by 2027 from $9.7 billion in 2021, at a CAGR of 16.2% from 2021 to 2027. Growth in this market is primarily driven by increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies. Browse 94 figures / charts and 87 tables in this 184 -page report to understand trends, opportunities and forecast in regenerative medicine market by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals (small molecules and biologics)), product (cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products), application (musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications), distribution channel (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World). Download sample report by clicking on below link https://www.lucintel.com/regenerative-medicine-market.aspx “Cell-based immunology and cell therapy products market is expected to remain the largest segment during the forecast period.” Based on product, the regenerative medicine market is segmented into cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products. Lucintel forecasts that the cell-based immunology and cell therapy products market is expected to remain the largest segment due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine. “Within the regenerative medicine market, the musculoskeletal disorders segment is expected to remain the largest application” Based on application the musculoskeletal disorders segment is expected to witness the highest growth over the forecast period due to increasing orthopedic diseases and rising geriatric population. “North America will dominate the regenerative medicine market in near future” North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics. Download Brochure of this report by clicking on https://www.lucintel.com/regenerative-medicine-market.aspx Major players of regenerative medicine market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Kite Pharma, Novartis, Vericel, Integra LifeSciences, Wright Medical, MiMedx, Osiris Therapeutics, Stryker, Spark Therapeutics, and Zimmer Biomet are among the major regenerative medicine providers. This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/regenerative-medicine-market.aspx or helpdesk@lucintel.com